Artykuły w czasopismach na temat „IDO/TDO”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „IDO/TDO”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Oweira, Hani, Imad Lahdou, Stefan Mehrle, Elias Khajeh, Rajan Nikbakhsh, Omid Ghamarnejad, Peter Terness, Christoph Reißfelder, Mahmoud Sadeghi i Ali Ramouz. "Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells". Journal of Clinical Medicine 11, nr 16 (16.08.2022): 4794. http://dx.doi.org/10.3390/jcm11164794.
Pełny tekst źródłaTerai, Londin, Rochani, Link, Lam, Kaushal, Bhushan, Orloff i Sato. "Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma". Cancers 12, nr 2 (10.02.2020): 405. http://dx.doi.org/10.3390/cancers12020405.
Pełny tekst źródłaKim, Chan, Joo Hoon Kim, Jin Sung Kim, Hong Jae Chon i Joo-Hang Kim. "A novel dual inhibitor of IDO and TDO, CMG017, potently suppresses the kynurenine pathway and overcomes resistance to immune checkpoint inhibitors." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): e14228-e14228. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14228.
Pełny tekst źródłaCampesato, Luis Felipe, Sadna Budhu, Jeremy Tchaicha, Abhinav Jaiswal, Mathieu Gigoux, Stephane Pourpe, Cailian Liu i in. "Blockade of IDO/TDO downstream effectors restricts cancer immune suppression". Journal of Immunology 202, nr 1_Supplement (1.05.2019): 137.3. http://dx.doi.org/10.4049/jimmunol.202.supp.137.3.
Pełny tekst źródłaThackray, Sarah J., Christopher G. Mowat i Stephen K. Chapman. "Exploring the mechanism of tryptophan 2,3-dioxygenase". Biochemical Society Transactions 36, nr 6 (19.11.2008): 1120–23. http://dx.doi.org/10.1042/bst0361120.
Pełny tekst źródłaOxenkrug, G. "Genetic and Environmental Impacts in Major Depressive Disorder are Mediated Via Kynurenine Pathway of Tryptophan Metabolism". European Psychiatry 24, S1 (styczeń 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70899-5.
Pełny tekst źródłaSUZUKI, Sachiko, Shigenobu TONÉ, Osamu TAKIKAWA, Toshikazu KUBO, Ichiro KOHNO i Yohsuke MINATOGAWA. "Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti". Biochemical Journal 355, nr 2 (6.04.2001): 425–29. http://dx.doi.org/10.1042/bj3550425.
Pełny tekst źródłaNienhaus, Karin, i G. Ulrich Nienhaus. "Co Recombination in Human IDO and TDO - A Comparison". Biophysical Journal 106, nr 2 (styczeń 2014): 676a. http://dx.doi.org/10.1016/j.bpj.2013.11.3744.
Pełny tekst źródłaSacramento, Jireh Joy D., i David P. Goldberg. "Oxidation of an indole substrate by porphyrin iron(iii) superoxide: relevance to indoleamine and tryptophan 2,3-dioxygenases". Chemical Communications 56, nr 20 (2020): 3089–92. http://dx.doi.org/10.1039/c9cc10019a.
Pełny tekst źródłaPaccosi, Sara, Marta Cecchi, Angela Silvano, Sergio Fabbri i Astrid Parenti. "Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines". Journal of Cancer Research and Clinical Oncology 146, nr 12 (10.08.2020): 3155–63. http://dx.doi.org/10.1007/s00432-020-03351-2.
Pełny tekst źródłaFunakoshi, Hiroshi, Masaaki Kanai i Toshikazu Nakamura. "Modulation of Tryptophan Metabolism, Promotion of Neurogenesis and Alteration of Anxiety-Related Behavior in Tryptophan 2,3-Dioxygenase-Deficient Mice". International Journal of Tryptophan Research 4 (styczeń 2011): IJTR.S5783. http://dx.doi.org/10.4137/ijtr.s5783.
Pełny tekst źródłaBadawy, Abdulla A.-B. "Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects". International Journal of Tryptophan Research 10 (1.01.2017): 117864691769193. http://dx.doi.org/10.1177/1178646917691938.
Pełny tekst źródłaYoshioka, Saeko, Tomonori Ikeda, Sogo Fukuchi, Yurika Kawai, Katsumi Ohta, Hisashi Murakami, Naohisa Ogo, Daisuke Muraoka, Osamu Takikawa i Akira Asai. "Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase". International Journal of Tryptophan Research 15 (styczeń 2022): 117864692211384. http://dx.doi.org/10.1177/11786469221138456.
Pełny tekst źródłaBadawy, Abdulla A.-B., i Gilles J. Guillemin. "Species Differences in Tryptophan Metabolism and Disposition". International Journal of Tryptophan Research 15 (styczeń 2022): 117864692211225. http://dx.doi.org/10.1177/11786469221122511.
Pełny tekst źródłaYeh, Syun-Ru, Ariel Lewis-Ballester i Shay Karkashon. "Comparative Studies of Human Indoleamine 2,3-Dioxygenase (IDO) and Tryptophan Dioxygenase (TDO)". Biophysical Journal 102, nr 3 (styczeń 2012): 467a. http://dx.doi.org/10.1016/j.bpj.2011.11.2560.
Pełny tekst źródłaTakkenkamp, Tim J., Mathilde Jalving, Frederik J. H. Hoogwater i Annemiek M. E. Walenkamp. "The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors". Endocrine-Related Cancer 27, nr 9 (wrzesień 2020): R329—R343. http://dx.doi.org/10.1530/erc-20-0113.
Pełny tekst źródłaLuques, Lisandro, Ashby Kissoondoyal, Emily De Sousa, Paula Quaglietta, David Malkin, Stefano Cairo, Emilie Indersie i Reto Baertschiger. "Abstract 3539: Indoleamine-2,3-dioxygenase 2 (IDO-2) is expressed in hepatoblastoma cells and associated with metastatic state". Cancer Research 83, nr 7_Supplement (4.04.2023): 3539. http://dx.doi.org/10.1158/1538-7445.am2023-3539.
Pełny tekst źródłaQin, Yanjie, Nanxi Wang, Xinlin Zhang, Xuemei Han, Xuejia Zhai i Yongning Lu. "IDO and TDO as a potential therapeutic target in different types of depression". Metabolic Brain Disease 33, nr 6 (16.07.2018): 1787–800. http://dx.doi.org/10.1007/s11011-018-0290-7.
Pełny tekst źródłaMuzik, O., F. John, S. Mittal i C. Juhasz. "P11.35 Fluorine-18-labeled PET radiotracers for imaging tryptophan uptake and metabolism in brain tumors". Neuro-Oncology 21, Supplement_3 (sierpień 2019): iii50—iii51. http://dx.doi.org/10.1093/neuonc/noz126.181.
Pełny tekst źródłaYe, Zixiang, Linxiu Yue, Jiachen Shi, Mingmei Shao i Tao Wu. "Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications". Journal of Cancer 10, nr 12 (2019): 2771–82. http://dx.doi.org/10.7150/jca.31727.
Pełny tekst źródłaJovanovic, Filip, Kenneth D. Candido i Nebojsa Nick Knezevic. "The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents". International Journal of Molecular Sciences 21, nr 17 (22.08.2020): 6045. http://dx.doi.org/10.3390/ijms21176045.
Pełny tekst źródłaNaismith, James H. "Tryptophan oxygenation: mechanistic considerations". Biochemical Society Transactions 40, nr 3 (22.05.2012): 509–14. http://dx.doi.org/10.1042/bst20120073.
Pełny tekst źródłaAshoura, Norah E., Joseph D. Dekker, Todd Triplett, Kendra Garrison, John Blazeck, Christos Karamitros, Candice Lamb i in. "The Force Awakens: Illuminating the role of kynurenine in cancer progression and treatment." Journal of Immunology 200, nr 1_Supplement (1.05.2018): 177.3. http://dx.doi.org/10.4049/jimmunol.200.supp.177.3.
Pełny tekst źródłaRafice, Sara A., Nishma Chauhan, Igor Efimov, Jaswir Basran i Emma Lloyd Raven. "Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase". Biochemical Society Transactions 37, nr 2 (20.03.2009): 408–12. http://dx.doi.org/10.1042/bst0370408.
Pełny tekst źródłaBadawy, Abdulla A.-B., i Gilles Guillemin. "The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal". International Journal of Tryptophan Research 12 (styczeń 2019): 117864691986897. http://dx.doi.org/10.1177/1178646919868978.
Pełny tekst źródłaOh, Angela. "Crystallization of heme dioxygenases IDO and TDO facilitates structure-based design of cancer immunology therapeutics". Acta Crystallographica Section A Foundations and Advances 76, a1 (2.08.2020): a45. http://dx.doi.org/10.1107/s0108767320099547.
Pełny tekst źródłaCampesato, Luis Felipe, Sadna Budhu, Jeremy Tchaicha, Stephane Pourpe, Cailian Liu, Mark G. Manfredi, Karen McGovern, Jedd D. Wolchok i Taha Merghoub. "Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target". Journal of Immunology 200, nr 1_Supplement (1.05.2018): 177.5. http://dx.doi.org/10.4049/jimmunol.200.supp.177.5.
Pełny tekst źródłaAlan, Wise, Mcguinness E. Barry, Cowley M. Phillip, Trewick C. Sarah, Bevan Nicola, Szybut Clare i Brown J. Thomas. "ITOC2 – 013. In vitro kynurenine modulation by novel dual-acting and selective TDO and IDO inhibitors". European Journal of Cancer 51 (marzec 2015): S5. http://dx.doi.org/10.1016/j.ejca.2015.01.026.
Pełny tekst źródłaYuasa, Hajime J., i Helen J. Ball. "Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes". Journal of Experimental Zoology Part B: Molecular and Developmental Evolution 324, nr 2 (20.02.2015): 128–40. http://dx.doi.org/10.1002/jez.b.22608.
Pełny tekst źródłaBadawy, Abdulla A. B., Aryan M. A. Namboodiri i John R. Moffett. "The end of the road for the tryptophan depletion concept in pregnancy and infection". Clinical Science 130, nr 15 (29.06.2016): 1327–33. http://dx.doi.org/10.1042/cs20160153.
Pełny tekst źródłaEl-Zahabi, Mohamed Ayman ALy, Mostafa Youssef Abouzeid, Ibrahim H. Eissa i Mohamed S. Taghour. "DUAL INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) AND TRYPTOPHAN-2,3-DIOXYGENASE (TDO) AS ANTI-TUMOR IMMUNE MODULATORS". Al-Azhar Journal of Pharmaceutical Sciences 69, nr 1 (1.03.2024): 38–61. http://dx.doi.org/10.21608/ajps.2024.360357.
Pełny tekst źródłaKim, C., N. K. Lee, J. S. Kim, W. R. Kim, D. H. Kim, D. J. Kim, J. S. Oh, S. K. Chang, J. W. Kim i H. J. Chon. "An oral dual inhibitor of IDO and TDO enhances anti-cancer immunity and synergizes with immune checkpoint blockade". Annals of Oncology 29 (październik 2018): viii416. http://dx.doi.org/10.1093/annonc/mdy288.039.
Pełny tekst źródłaLiu, Xiangdong, Niu Shin, Holly K. Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet i in. "Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity". Blood 115, nr 17 (29.04.2010): 3520–30. http://dx.doi.org/10.1182/blood-2009-09-246124.
Pełny tekst źródłaBrincks, Erik L., James Adams, Lifu Wang, Benjamin Turner, Agnieszka Marcinowicz, Jiyuan Ke, Michael Essmann i in. "Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1". Oncotarget 11, nr 25 (23.06.2020): 2438–61. http://dx.doi.org/10.18632/oncotarget.27646.
Pełny tekst źródłaBerthon, Céline, Michaela Fontenay, Selim Corm, Isabelle Briche, Michel Lhermitte i Bruno Quesnel. "Metabolites of Tryptophan Catabolism Are Elevated in Sera of Patients with Myelodysplastic Syndromes and Inhibit Hematopoietic Progenitor Amplification". Blood 120, nr 21 (16.11.2012): 3843. http://dx.doi.org/10.1182/blood.v120.21.3843.3843.
Pełny tekst źródłaPetrovic, Vladimir, Jamie Wong, Cedric E. Dos Santos, Richard Smith, Dan Fitzpatrick, Robert Loberg i Ariel Avilion. "IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma". Blood 132, Supplement 1 (29.11.2018): 5572. http://dx.doi.org/10.1182/blood-2018-99-111392.
Pełny tekst źródłaBooth, Nicholas, Wells Brockbank, Samuel Oh i Karl Kingsley. "Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated". Journal of Molecular Pathophysiology 1, nr 1 (2012): 29. http://dx.doi.org/10.5455/jmp.20120609040915.
Pełny tekst źródłaChen, Xiangli, Yuzhu Zang, Dujuan Li, Jianmin Guo, Yacai Wang, Yuqi Lin i Zhenghong Wei. "IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era". Medicine 99, nr 21 (22.05.2020): e19883. http://dx.doi.org/10.1097/md.0000000000019883.
Pełny tekst źródłaStone, Trevor W., i Richard O. Williams. "Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface". Cancers 15, nr 11 (24.05.2023): 2895. http://dx.doi.org/10.3390/cancers15112895.
Pełny tekst źródłaJovanovic, Filip, Aboorva Sudhakar i Nebojsa Nick Knezevic. "The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator". International Journal of Tryptophan Research 15 (styczeń 2022): 117864692210992. http://dx.doi.org/10.1177/11786469221099214.
Pełny tekst źródłaNoakes, Rowland R. "Effects of Tranilast on the Urinary Excretion of Kynurenic and Quinolinic Acid under Conditions of L Tryptophan Loading". International Journal of Tryptophan Research 6 (styczeń 2013): IJTR.S12797. http://dx.doi.org/10.4137/ijtr.s12797.
Pełny tekst źródłaKubacka, Justyna, Anna Stefańska i Grażyna Sypniewska. "Kynurenine pathway: the link between depressive disorders and inflammation". Postępy Higieny i Medycyny Doświadczalnej 74 (6.08.2020): 331–39. http://dx.doi.org/10.5604/01.3001.0014.3454.
Pełny tekst źródłaSpector, Sydney, Chunjing Wu, Dan Nguyen, George Theodore, Ashley Garcia, Lynn Feun, Niramol Savaraj i Medhi Wangpaichitr. "Abstract 2325: Targeting kynurenine pathway using novel IDO/TDO dual inhibitor (AT0174) to modulate tumor microenvironment in platinum resistant non-small cell lung cancer cancer: An immunometabolism compliment markers". Cancer Research 82, nr 12_Supplement (15.06.2022): 2325. http://dx.doi.org/10.1158/1538-7445.am2022-2325.
Pełny tekst źródłaPal, Anasua, Philipp Zimmer, Dorothea Clauss, Martina E. Schmidt, Cornelia M. Ulrich, Joachim Wiskemann i Karen Steindorf. "Resistance Exercise Modulates Kynurenine Pathway in Pancreatic Cancer Patients". International Journal of Sports Medicine 42, nr 01 (24.07.2020): 33–40. http://dx.doi.org/10.1055/a-1186-1009.
Pełny tekst źródłaGiannakis, Marios, Haoxin Li, Chelsea Jin, Shuba Gopal, Kaushal Desai, Christine Horak, Megan Wind-Rotolo i in. "Metabolomic correlates of response in nivolumab-treated renal cell carcinoma and melanoma patients." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): 3036. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3036.
Pełny tekst źródłaPires, Ananda Staats, Shabarni Gupta, Sean A. Barton, Roshana Vander Wall, Vanessa Tan, Benjamin Heng, Jacqueline K. Phillips i Gilles J. Guillemin. "Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease". International Journal of Tryptophan Research 15 (styczeń 2022): 117864692211260. http://dx.doi.org/10.1177/11786469221126063.
Pełny tekst źródłaPapadopoulos, Kyriakos, Michael Cecchini, Juanita S. Lopez, Dirk Jäger, Ki Young Chung, Michael Platten, Florian Prinz i in. "Abstract CT276: Preliminary analysis of pharmacokinetic (PK) and target engagement biomarkers from a first in human phase 1 study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964". Cancer Research 83, nr 8_Supplement (14.04.2023): CT276. http://dx.doi.org/10.1158/1538-7445.am2023-ct276.
Pełny tekst źródłaDawood, Shazia, Samina Bano i Abdulla Abu-Bakr Badawy. "Inflammation and serotonin deficiency in major depressive disorder: Molecular docking of antidepressant and antiinflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases". Bioscience Reports, 4.05.2022. http://dx.doi.org/10.1042/bsr20220426.
Pełny tekst źródłaGualdoni, Gisela S., Patricia V. Jacobo, Cristian M. Sobarzo, Cecilia V. Pérez, María E. Matzkin, Christian Höcht, Mónica B. Frungieri i in. "Role of indoleamine 2,3-dioxygenase in testicular immune-privilege". Scientific Reports 9, nr 1 (4.11.2019). http://dx.doi.org/10.1038/s41598-019-52192-8.
Pełny tekst źródłaOxenkrug, Gregory, i Valeriya Navrotska. "Extension of life span by down-regulation of enzymes catalyzing tryptophan conversion into kynurenine: Possible implications for mechanisms of aging". Experimental Biology and Medicine, 10.06.2023, 153537022311794. http://dx.doi.org/10.1177/15353702231179411.
Pełny tekst źródła